William Blair & Company
TCRT icon

William Blair & Company’s Alaunos Therapeutics TCRT Stock Holding History

William Blair & Company’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-625
Closed -$6.63K – 1850
2023
Q4 		$6.63K Hold
625
– – ﹤0.01% 1730
2023
Q3 		$12.4K Hold
625
– – ﹤0.01% 1711
2023
Q2 		$47.8K Hold
625
– – ﹤0.01% 1603
2023
Q1 		$59K Hold
625
– – ﹤0.01% 1565
2022
Q4 		$60.8K Hold
625
– – ﹤0.01% 1554
2022
Q3 		$161K Hold
625
– – ﹤0.01% 1434
2022
Q2 		$116K Buy
+625
New +$59.7K ﹤0.01% 1515
2019
Q3 		– Sell
-397
Closed -$347K – 1755
2019
Q2 		$347K Sell
397
-194
-33% -$133K ﹤0.01% 1106
2019
Q1 		$341K Hold
591
– – ﹤0.01% 1099
2018
Q4 		$166K Buy
591
+10
+2% +$3.95K ﹤0.01% 1258
2018
Q3 		$279K Hold
581
– – ﹤0.01% 1174
2018
Q2 		$263K Buy
+581
New +$368K ﹤0.01% 1174
2016
Q1 		– Sell
-93
Closed -$117K – 1238
2015
Q4 		$117K Buy
+93
New +$154K ﹤0.01% 1139

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

William Blair & Company's TCRT Position: Q1 2024 in Review

William Blair & Company sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 625 shares — an estimated $6.63K sold.

William Blair & Company first reported a position in TCRT in Q4 2015 and held it in 13 quarters. The position peaked at $347K in Q2 2019. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • William Blair & Company reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • William Blair & Company sold 625 Alaunos Therapeutics shares in Q1 2024, an estimated $6.63K.
  • William Blair & Company first reported a position in Alaunos Therapeutics in Q4 2015 and held it in 13 quarters.
  • William Blair & Company's Alaunos Therapeutics position peaked at $347K in Q2 2019.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on William Blair & Company's 13F filing for Q1 2024, filed 9 May 2024.